Yasuo Yamamoto Selected Research

Yasuo Yamamoto Research Topics

Disease

3	Dermatitis 08/2021 - 08/2016
3	Contact Dermatitis (Eczema, Contact) 01/2021 - 12/2016
3	Atopic Dermatitis (Atopic Eczema) 02/2020 - 09/2015
3	Pruritus (Itching) 02/2020 - 08/2016
3	Type 2 Diabetes Mellitus (MODY) 01/2014 - 09/2010
2	Neoplasm Metastasis (Metastasis) 12/2023 - 07/2004
2	Inflammation (Inflammations) 01/2018 - 12/2016
2	Hyperglycemia 01/2014 - 10/2013
1	Neoplasms (Cancer) 12/2023
1	Carcinoma (Carcinomatosis) 12/2023
1	Fibrosis (Cirrhosis) 12/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Hyperaldosteronism (Conn Syndrome) 01/2022
1	Heart Failure 01/2022
1	Drug Eruptions (Drug Eruption) 08/2021
1	Experimental Arthritis 03/2021
1	Osteoporosis 03/2021
1	Rheumatoid Arthritis 03/2021
1	Hypersensitivity (Allergy) 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 05/2017
1	Fatty Liver 02/2016
1	Prostatic Neoplasms (Prostate Cancer) 07/2004
1	Bone Resorption 07/2004

Drug/Important Bio-Agent (IBA)

4	Glucose (Dextrose)FDA LinkGeneric 01/2014 - 09/2010
3	delgocitinibIBA 02/2020 - 12/2016
3	Janus Kinase InhibitorsIBA 02/2020 - 12/2016
3	SodiumIBA 10/2013 - 09/2010
2	GlucocorticoidsIBA 03/2021 - 05/2017
2	Tacrolimus (Prograf)FDA LinkGeneric 02/2018 - 01/2018
2	CytokinesIBA 01/2018 - 12/2016
2	Blood Glucose (Blood Sugar)IBA 01/2014 - 10/2013
2	GlucosidesIBA 01/2014 - 09/2010
2	CanagliflozinIBA 09/2013 - 09/2010
1	pembrolizumabIBA 12/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2023
1	Type 1 Melanocortin ReceptorIBA 12/2022
1	Melanocyte-Stimulating Hormones (MSH)IBA 12/2022
1	apararenoneIBA 01/2022
1	AldosteroneIBA 01/2022
1	Eplerenone (Inspra)FDA LinkGeneric 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022
1	apalutamideIBA 08/2021
1	JTP-117968IBA 03/2021
1	LipopolysaccharidesIBA 03/2021
1	resiniferatoxinIBA 01/2021
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2021
1	TRPA1 Cation ChannelIBA 02/2018
1	InterleukinsIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Ointments (Pastes)IBA 01/2018
1	Thymic Stromal LymphopoietinIBA 01/2018
1	Immunoglobulin E (IgE)IBA 01/2018
1	Janus KinasesIBA 01/2018
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2018
1	Interleukin-23 (Interleukin 23)IBA 01/2018
1	HaptensIBA 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	Irritants (Vesicants)IBA 12/2016
1	Croton OilIBA 12/2016
1	AntigensIBA 12/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2016
1	Imiquimod (Aldara)FDA LinkGeneric 08/2016
1	Choline (Choline Chloride)IBA 02/2016
1	AllergensIBA 09/2015
1	indoleIBA 01/2014
1	Sodium-Glucose Transport ProteinsIBA 01/2014
1	ThiophenesIBA 09/2010
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 07/2004
1	AndrogensIBA 07/2004
1	Collagen Type I (Type I Collagen)IBA 07/2004
1	Procollagen Type IIBA 07/2004
1	Peptides (Polypeptides)IBA 07/2004
1	pyridinolineIBA 07/2004

Therapy/Procedure

2	Therapeutics 12/2023 - 01/2018
2	Oral Administration 01/2018 - 12/2016
1	Immunotherapy 12/2023
1	Drug Tapering 08/2021
1	Denervation 01/2021